Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
210 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
February 11, 2026
Extension Available
Until February 11, 2026
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 11, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 11, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 11, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 11, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 11, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 11, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 17, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 17, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 17, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 17, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 17, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 21, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 12, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 12, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 12, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 10, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
Class 044
Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
Additional Information
Pseudo Mark
THINK INTRAVENOUS IMMUNOGLOBULIN
Classification
International Classes
035
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IVIG"